Lobbying Information
Subject Matters
- Health
- Science and Technology
Subject matters added through a monthly communication report
Subject Matter Details
Grant, Contribution or Other Financial Benefit
- Seeking funding, source of funding to be determined, for clinical trials for the development of a new immune-modular drug ARDS-003 for the treatment of acute respiratory distress syndrome (ARDS) to prevent escalation of COVID-19 to Sepsis.
Seeking financial support, amount to be determined, such as grants, loans or other financial products to promote product development, promote investment in research and development (R&D) and promote investments to support the commercialization and industrialization of its products.
Communication Techniques
-
Written communication
-
Oral communication
The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.
Government Institutions
-
Business Development Bank of Canada (BDC)
-
Canada Economic Development for Quebec Regions
-
Health Canada (HC)
-
House of Commons
-
Innovation, Science and Economic Development Canada (ISED)
-
Prime Minister's Office (PMO)
-
Public Health Agency of Canada (PHAC)
-
Senate of Canada
Client Details
Government funding
No government funding was received during the last completed financial year.
Client Contact Information
Address:
2316 St-Joseph boul.
Orleans, ON K1C 1E8
Canada
Telephone number:
343-780-2020
Ext.
235
Client representative
Natalie Leroux, Director, Licensing and Governmental Affairs
Parent Company Information
Tetra Bio-Pharma Inc is not a subsidiary of any other parent companies.
Coalition Members Information
Tetra Bio-Pharma Inc is not a coalition.
Individual, organization or corporation with a Direct Interest Beneficiary Information
The activities of Tetra Bio-Pharma Inc are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Subsidiary Beneficiary Information
Tetra Bio-Pharma Inc does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Lobbyist Details
ALAIN PILON
|
Public offices held
Business address:
46 Elgin Street
Suite 100
OTTAWA, ON K1P 5K6
Canada
Telephone number:
613-567-2699
Fax number:
613-567-6803
Consultant Firm and Address
Firm:
THE ROTHWELL GROUP INC.
Address:
46 Elgin Street
Suite 400
OTTAWA, ON K1P 5K6
Canada
Telephone number:
613-850-9131
